Project Grant R21NS136831

Award Date 9/20/24
Completion Date 9/19/26
Dollars Obligated $446K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Boston, MA 02215, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $361,975 to support research focused on developing chemical strategies for imaging and manipulating astrocytes in the brain. The project aims to expand the capabilities of an astrocyte-targeting chemical tag to enable direct visualization and modulation of astrocyte...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $168,455 to New York University School of Medicine to investigate the role of region-specific reactive astrocyte factors in neuroinflammation. The key objectives are to: Assess the effect of hepatocyte growth factor (HGF) expressed by telencephalic reactive astrocytes on...
This Project Grant award, valued at $481,250.00 and provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop a synthetic biological system to manipulate subcellular RNAs and proteins in growth cones or synapses of subtype- and context-specific neurons. The goal is to enable unique forms of subcellular functional investigation in subtype- and...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA 93.310 - Trans-NIH Research Support program totals $1,490,348 and is aimed at testing an integrative hypothesis about the role of astrocytes in the brain's neuromodulator signaling systems. The award, made to the Research Foundation For Mental Hygiene, Inc. (RFMH) doing business as the New York Psychiatric Center, will utilize state-of-the-art cellular imaging and spatial transcriptomics...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders provides $499,979 to The Salk Institute for Biological Studies to conduct research on the role of astrocytes in neuropathic pain. The key objectives are to: 1) determine how peripheral nerve injury alters dorsal horn astrocyte function, 2) elucidate how targeted interventions control dorsal horn...
This federal Project Grant award of $629,031.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research to develop a novel optical imaging technique called Optical Cell State Imaging (OCSI) that can track neural stem cell activation state in living cells without exogenous labeling. The key products and services to be delivered...
This $538,523 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports the development of an innovative imaging and computational platform for integrated analysis of biodata. The platform aims to enable rapid and unbiased analysis of entire organs at subcellular resolution, with a focus on studying glial cell development in the mouse forebrain. The...
This federal Project Grant award of $221,120.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to improve neural progenitor (NP) survival and migration for the treatment of neurodegenerative diseases and brain injuries. The project investigates the potential of adult central nervous system (CNS) endothelial cells to express developmental...
This federal Project Grant award of $460,500 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) is aimed at developing novel bioprinting methodologies for the production of human stem cell-based organoids. The key objectives are to: 1) Create a customized bioink formulation using proteins, polysaccharides, and functionalized nanoparticles to foster the...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $2,503,949 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Rockefeller University. The grant, awarded on May 1, 2025, supports a research project titled "Applying RNA Logic in Space and Time to Neurologic Disease". The project aims to develop new techniques and concepts to discover therapeutic targets for neurological diseases by studying...

This federal Project Grant award of $446,126 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop a new bioassay to study astrocyte borders and profile their functional states in the context of diverse non-neural cell populations.

The key objectives are to optimize the bioassay by combining injectable cellulose-based hydrogels with viral vectors to enable astrocyte-specific mRNA recovery and profiling via RNA-sequencing. The project will also evaluate astrocyte border states at non-neural niches with varying immune cell compositions, created by modifying the hydrogel properties. This work is expected to identify conserved and context-dependent mechanisms involved in astrocyte border formation and function, providing a foundation to explore therapeutic targeting of astrocyte borders for central nervous system disorders and improved medical device biocompatibility.

Generated 7/1/25, 3:28 AM